Sign In
Sign In
The $280 billion drug-benefit industry has fought off efforts by a number of states to impose a fiduciary standard by arguing that U.S. employment law takes precedence. (Image: Shutterstock)Recommended Stories
A rollercoaster year for ERISA litigation
7 key takeaways from recent court cases that employers, brokers, and advisors need to be aware of as litigation increases in 2021.
Cost of insurance keeping many Americans from replacing coverage lost in 2020
The loss of coverage was exceptionally high for those who were laid off or furloughed because of the coronavirus pandemic.
A potential game changer for student loan debt: The Employer Participation in Repayment Act
Here's what this provision means for the millions of American employees burdened by student debt.
Resource Center
White Paper
Sponsored by ArmadaCare
Emerging Trends in Employee Benefits
Discover how to make benefits packages better in 2021 by addressing what clients and their employees find most important.
Guide
Sponsored by Nonstop Administration and Insurance Services, Inc.
Using First-Dollar Coverage to Optimize Employee Health Benefits
Get details on an innovative coverage approach to health plan design to help clients improve the financial security and well-being of their workforces.
White Paper
Sponsored by HealthEquity
Six Strategies to Reduce Benefits Costs in 2021
Benefits costs continue to rise, but there are proven strategies to help clients take control.
BenefitsPRO Broker Expo 2021Event
Get More Information
BenefitsPRO
Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!
- Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
- Exclusive discounts on BenefitsPRO.com and ALM events.
Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.